Literature DB >> 6795718

Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.

I S Kazmers, B S Mitchell, P E Dadonna, L L Wotring, L B Townsend, W N Kelley.   

Abstract

The guanosine analog 8-aminoguanosine is an effective inhibitor of the purine degradative enzyme purine nucleoside phosphorylase, both in vitro and in intact lymphoid cells. In a human lymphoblast tissue culture system, 8-aminoguanosine, in combination with low concentrations of 2'-deoxyguanosine, causes toxicity toward T cells but not B cells. The selective T cell toxicity correlates with increased accumulation of deoxyguanosine triphosphate in the treated T lymphoblasts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795718     DOI: 10.1126/science.6795718

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  26 in total

1.  Preliminary crystallographic studies of purine nucleoside phosphorylase from the cariogenic pathogen Streptococcus mutans.

Authors:  Qiao Ming Hou; Xiang Liu; Erik Brostromer; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

2.  Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.

Authors:  Kumudha Balakrishnan; Jan A Burger; Maite P Quiroga; Marina Henneberg; Mary L Ayres; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

3.  A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).

Authors:  Varsha Gandhi; John M Kilpatrick; William Plunkett; Mary Ayres; Leigh Harman; Min Du; Shanta Bantia; Jan Davisson; William G Wierda; Stefan Faderl; Hagop Kantarjian; Deborah Thomas
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

4.  Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.

Authors:  R B Gilbertsen; M E Scott; M K Dong; L M Kossarek; M K Bennett; D J Schrier; J C Sircar
Journal:  Agents Actions       Date:  1987-08

5.  The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.

Authors:  W R Osborne; C R Scott
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

6.  B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.

Authors:  A Goday; H A Simmonds; G S Morris; L D Fairbanks
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

Review 7.  Metabolic defects in immunodeficiency diseases.

Authors:  A D Webster
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Purine metabolism by intracellular Chlamydia psittaci.

Authors:  G McClarty; H Fan
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

9.  In situ studies on incorporation of nucleic acid precursors into Chlamydia trachomatis DNA.

Authors:  G McClarty; G Tipples
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

10.  8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2016-09-27       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.